Stanislas Blein

Title: The Innovations of Stanislas Blein

Introduction

Stanislas Blein is a notable inventor based in Briançon, France. He has made significant contributions to the field of medical science, particularly in the treatment of inflammatory diseases. His work focuses on innovative methods that utilize antagonists against Tumor Necrosis Factor Receptor 1 (TNFR1).

Latest Patents

Stanislas Blein holds a patent for "Antagonists against TNFR1 and methods of use therefor." This invention provides methods for treating chronic inflammatory diseases by administering an antagonist of TNFR1. The patent also includes ligands that contain an immunoglobulin single variable domain (domain antibody, dAb) monomer that binds TNFR1. Additionally, it covers nucleic acids encoding the ligands, recombinant host cells, and methods for preparing these ligands. He has 1 patent to his name.

Career Highlights

Stanislas Blein is associated with Domantis Limited, a company that focuses on developing innovative therapeutic solutions. His work at Domantis has allowed him to explore and implement groundbreaking ideas in the field of immunology.

Collaborations

Throughout his career, Stanislas has collaborated with notable colleagues, including Neil D Brewis and Benjamin P Woolven. These collaborations have contributed to the advancement of his research and the successful development of his inventions.

Conclusion

Stanislas Blein's contributions to the field of medical science through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for new treatments for inflammatory diseases.